Europe — EMA

Ondansetron 1 A Pharma

Ondondansetron, the active ingredient in Ondansetron 1 A Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron 1 A Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients.

GNH USA supplies Ondansetron 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron is a selective ... ... .... .... ... ... ... ... .... ... ... ... ... .... ... ... .... ... ...

What are the side effects of Ondansetron?

Common .... ........

What precautions apply to Ondansetron?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →